An overview of beta-amyloid cleaving enzyme (BACE1) in Alzheimer’s disease therapy: Elucidating its exosite-binding antibody and allosteric inhibitor An overview of beta-amyloid cleaving enzyme (BACE1) in Alzheimer’s disease therapy: Elucidating its exosite-binding antibody and allosteric inhibitor Curr Med Chem Curr Med Chem 2022 2022 29 29 114 114 135 135 10.2174/0929867328666210608145357 10.2174/0929867328666210608145357 34102967 34102967. Here, BACE1 is linked to Alzheimer disease.